CVS beats Q3 revenue, profit estimates, outlook raised; to split into two
CVS beats Q3 revenue, profit estimates, outlook raised; to split into two
Overview
US health solutions firm's Q3 revenue rose 5.4%, beating analyst expectations
Q3 adjusted EPS increased to $2.09, beating analyst expectations
Company raised full-year 2026 guidance for EPS and cash flow from operations
CVS to split in two, separating pharmacy business from insurance
Outlook
CVS raises full-year 2026 GAAP diluted EPS guidance to at least $6.98 from $6.84-$7.04
Company lifts 2026 adjusted EPS guidance to at least $8.20 from $7.90-$8.10
CVS increases 2026 cash flow from operations guidance to at least $15.5 bln from $11.5 bln
Result Drivers
HEALTH SERVICES GROWTH - Revenue in the Health Services segment rose 9.5%, driven by pharmacy drug mix and brand inflation, partly offset by pharmacy client price improvements
HEALTH CARE BENEFITS IMPROVEMENT - Adjusted operating income in the Health Care Benefits segment rose, mainly due to improved performance in the Government business
RETAIL PHARMACY PRESSURE - Pharmacy & Consumer Wellness revenue fell 2.0% due to regulatory-related price reductions, new generic drug introductions, and reimbursement pressure, partly offset by increased prescription volume and brand inflation
Company press release: ID:nPn9XhqbCa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | Beat | $108.40 bln | $104.69 bln (19 Analysts) |
Q3 Adjusted EPS | Beat | $2.09 | $1.65 (24 Analysts) |
Q3 EPS |
| $1.68 |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 25 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for CVS Health Corporation is $112.00, about 22.5% above its November 3 closing price of $91.41
The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 13 three months ago
Reuters Recommended Reads
Nov 3 - CVS Health explores splitting retail pharmacy, insurance businesses, FT reports
Nov 3 - Senior care provider InnovAge's Q1 revenue beats as participants increase
Nov 3 - Addus HomeCare Q3 adjusted EPS beats estimates; to acquire AccentCare personal care division
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on CVS Health
See all newsHealth Rounds: GLP-1 drugs tied to heart improvements in patients with obesity and heart failure
US health insurers fall for third day on CMS audit proposal, Medicare-for-All concerns
Health insurers extend decline on proposed new rule to curb fraud
Health insurers extend decline on proposed new rule to curb fraud
UnitedHealthcare to expand program paying pharmacists for medical services